Artificial Pancreas Device System Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis

The Artificial Pancreas Device System Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Artificial Pancreas Device System Market Size and Its Estimated Growth Rate?
The artificial pancreas device system market has expanded swiftly, forecasted to grow from $1.81 billion in 2024 to $2.07 billion in 2025 at a CAGR of 14.1%, driven by rising investments, growing clinical research initiatives by governments, technological advances in glycemic control, industry-led R&D, and a growing elderly population.

The artificial pancreas device system market is set to grow quickly, reaching $3.48 billion in 2029 at a CAGR of 13.9%, spurred by rising diabetes rates, pancreatic disease prevalence, and demand for non-invasive drug delivery; trends involve product innovation, telehealth follow-up, and collaborative R&D.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18229

How Are Emerging Segments Shaping the Artificial Pancreas Device System Market Landscape?
The artificial pancreas device system market covered in this report is segmented -

1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid
3) By End-User: Hospitals, Medical Centers, Other End-Users

Subsegments:
1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend, Continuous Glucose Monitoring (CGM) Integrated Systems
2) By Control-To-Range Systems: Hybrid Closed-Loop Systems, Insulin Delivery Systems with Range Control, Real-Time Glucose Adjustment Systems
3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems, Insulin Pumps with Targeted Glucose Control, Automated Glucose Regulation Systems

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp

Which Growth Factors Are Influencing Artificial Pancreas Device System Market Expansion?
An increase in pancreatic cancer cases is projected to boost the artificial pancreas device system market. Pancreatic cancer stems from both genetic and lifestyle factors and contributes to chronic pancreas inflammation. Although primarily for diabetes management, APDS helps patients by monitoring glucose and dispensing insulin. In March 2024, Cancer Australia estimated 4,506 new pancreatic cancer cases for 2023, up from 3,751 over the past five years. Hence, rising pancreatic cancer cases are promoting growth in the artificial pancreas device system market.

Who Are the Dominant Players Across Different Artificial Pancreas Device System Market Segments?
Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd

What Trends Are Expected to Dominate the Artificial Pancreas Device System Market in the Next 5 Years?
Leading companies in the artificial pancreas device system market are working on automated insulin delivery systems to improve diabetes management by automatically regulating blood glucose and insulin levels. These systems replicate the pancreas' function, reducing the need for manual monitoring and insulin injections. For instance, in May 2023, Beta Bionics, a US-based company, received FDA clearance for its iLet Insulin-Only Bionic Pancreas System. This system adjusts insulin delivery based on glucose levels measured by a connected continuous glucose monitor (CGM).

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/artificial-pancreas-device-system-global-market-report

Which Geographic Regions Are Expected to Dominate the Artificial Pancreas Device System Market in the Coming Years?
North America was the largest region in the artificial pancreas device system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Artificial Pancreas Device System Market?
2. What is the CAGR expected in the Artificial Pancreas Device System Market?
3. What Are the Key Innovations Transforming the Artificial Pancreas Device System Industry?
4. Which Region Is Leading the Artificial Pancreas Device System Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.